Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the study page, likely due to editorial or QC updates.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision metadata updated from v3.6.0 to v3.6.2, indicating a newer version deployed for the page. This appears to be a backend/template update rather than a change to the study information.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew navigational sections and attribution lines have been added, and older labels removed, reflecting a refresh of the study page structure and metadata.SummaryDifference1%

- Check35 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new build of the page. This is a minor metadata update and does not modify any study details or content presented on the page.SummaryDifference0.1%

- Check57 days agoChange DetectedAn updated page revision tag v3.5.4 is displayed, replacing the previous v3.5.3. This reflects a maintenance or update to the page's versioning rather than changes to trial data or content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s footer software/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.